ConductScience.org, home

Paper309354

Unexpected longevity of a patient with malignant pleural mesothelioma: report of a case.

Fischbein A and 3 others. Cancer, 1978. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Unexpected longevity of a patient with malignant pleural mesothelioma: report of a case. Papers, record 309354. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/309354

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Unexpected longevity of a patient with malignant pleural mesothelioma: report of a case.
PubMed
Journal
Cancer
PubMed
Year
1978
PubMed
Publication types
Case Reports, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.54
iCite
Revised in PubMed
2019-06-19
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fischbein AA
2Suzuki YY
3Selikoff IJI J
4Bekesi JGJ G

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MesotheliomaMajor topic
Pleural NeoplasmsMajor topic
B-Lymphocytes
Humans
Lymphocyte Activation
Male
Middle Aged
Mitogens
T-Lymphocytes
Time Factors

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
21162719Mesothelioma and asbestosis in a young woman following occupational asbestos exposure: Short latency and long survival: Case Report.Diagn Pathol2010https://conductscience.org/library/papers/21162719PubMed
9539011Selected new developments in asbestos immunotoxicity.Environ Health Perspect1998https://conductscience.org/library/papers/9539011PubMed
8333148
Diffuse malignant mesothelioma of the pleura: a clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival.
Virchows Arch A Pathol Anat Histopathol1993https://conductscience.org/library/papers/8333148PubMed
6761970Diffuse malignant mesothelioma: a review.West J Med1982https://conductscience.org/library/papers/6761970PubMed
4042419Immune function and survival in pleural mesothelioma.Clin Exp Immunol1985https://conductscience.org/library/papers/4042419PubMed
3210656Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from 1981-1985.Klin Wochenschr1988https://conductscience.org/library/papers/3210656PubMed
316753Sequential immunological studies on an asbestos-exposed population. I. Factors affecting peripheral blood leucocytes and T lymphocytes.Clin Exp Immunol1979https://conductscience.org/library/papers/316753PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/309354

GET https://conductscience.org/api/papers/v1/309354/authors